Massachusetts Board of Pharmacy Enacts Emergency Regulations Targeting Compounding Activities and Impacting All Registered and Licensed Pharmacies

by Holland & Knight LLP
Contact

The Massachusetts Board of Pharmacy (BOP) enacted emergency regulations effective November 1, 2012, in response to the deadly fungal meningitis outbreak caused by drug contamination at a Massachusetts compounding pharmacy.1 Most significantly, the regulations require pharmacies to report extensive data to the BOP regarding their compounding activities. In addition, the regulations implemented new reporting obligations that affect all registered pharmacies and pharmacists in the state and granted the BOP greater authority to quickly shut down pharmacies and quarantine products in the event of immediate public health and safety concerns.

Reporting on Sterile Compounding Activity

The emergency regulations require all licensed pharmacies that perform central intravenous admixture services (CIVAS) or sterile compounding to submit the following information to BOP every six months:

  • the total number of prescriptions dispensed
  • distribution data identifying the states in which the prescriptions were distributed
  • the status of any non-resident licenses issued by other states
  • clean room hood certifications required by Massachusetts regulations
  • status of CIVAS approvals where applicable

Pharmacies submitting this information must include an affidavit attesting to compliance with all laws and regulations related to sterile compounding. This attestation requires that pharmacies only prepare and dispense medication pursuant to a valid prescription for a single patient, indicating the BOP's concern that compounding pharmacies have been mass-producing medications similar to pharmaceutical manufacturers, which is potentially in violation of state licensure requirements.

Reporting of Disciplinary Actions and Change in Accreditation Status

All pharmacies and pharmacists registered or licensed in Massachusetts must report to the BOP all "non-routine notices, correspondence and disciplinary actions" within seven business days of receipt. These disciplinary actions include, but are not limited to:

  • the revocation, suspension, probation, censure, reprimand or restriction of a license to operate a pharmacy or practice pharmacy
  • the denial of an application for the renewal of a pharmacy license
  • the denial or restriction of privileges to practice pharmacy
  • termination from Medicare or state Medicaid programs
  • adverse actions or fines imposed by any state or federal agency

Pharmacies and pharmacists must also report any adverse change in status of accreditation within seven business days. The new regulations also require every pharmacy and pharmacist to provide the BOP with any responsive documents the pharmacy or pharmacist submitted to a government agency in connection with an event listed above.

Reporting Adverse Events

All pharmacies must now report within seven business days all adverse events relating to the preparation of medication in the pharmacy. Regulations previously required the reporting only of improper dispensing of prescriptions which result in serious injury or death. In addition, pharmacies must report any abnormal results, including the failure to be certified to operate a pharmacy in the state, and identification of any environmental contaminants in the pharmacy.

Cease and Desist and Quarantine Authority

The BOP also may impose a summary cease and desist notice before a hearing takes place in order to stop or to restrict operations "to immediately protect the public health, safety or welfare." Similarly, the board may issue a summary quarantine of products prior to a hearing in order to prevent the use of medications prepared by or in possession of a registered or licensed pharmacy for safety reasons. These orders remain in effect until rescinded by the board or until the board issues a final decision. A hearing must be granted to the registered or licensed pharmacy within 21 days of the board action.

While these emergency regulations are effective immediately, the Massachusetts BOP has granted a 90-day comment period, including a public hearing, to consider changes before taking a final vote.

Impact of Regulations

These regulations will provide the Massachusetts BOP with significantly more data on the activities of licensed pharmacies and will likely result in additional inquiries into these activities. Compounding pharmacies should expect BOP to scrutinize the scope, volume, and nature of compounding activities both inside and outside of the Commonwealth. Moreover, all pharmacies and pharmacists should be aware that BOP now has the ability to monitor adverse actions against their licensure or certification in all states.

We will continue to monitor the impact of these emergency regulations on Massachusetts-licensed pharmacies as well as other upcoming regulatory developments concerning pharmacy compounding in Massachusetts and other states.

Written by:

Holland & Knight LLP
Contact
more
less

Holland & Knight LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.